Abstract
Background/objectives
Phytoestrogen rich-foods such as soy may be associated with less frequent/severe vasomotor menopausal symptoms (VMS), although evidence is limited. We thus investigated the associations between the consumption of soy products and soy milk and the frequency/severity of VMS.
Subjects/methods
We pooled data from 19,351 middle-aged women from five observational studies in Australia, UK, USA, and Japan that contribute to the International Collaboration for a Life course Approach to reproductive health and Chronic disease Events (InterLACE). Information on soy consumption, VMS and covariates were collected by self-report. We included 11,006 women who had complete data on soy consumption, VMS and covariates at baseline for the cross-sectional analysis. For the prospective analysis, 4522 women who were free of VMS at baseline and had complete data on VMS at follow-up were considered. Multinomial logistic regression and binary logistic regression models were used.
Results
No statistically significant evidence of an association was found between soy products (relative risk ratio (RRR): 0.92, 95% CI: 0.76–1.11) or soy milk (RRR: 1.24, 95% CI: 0.93–1.65) and the likelihood of reporting frequent or severe VMS cross-sectionally. Prospective results indicated that frequent consumption of soy products (odds ratio (OR): 0.63, 95% CI: 0.45–0.89) but not soy milk (OR: 1.11, 95% CI: 0.85–1.45) was associated with lower likelihood of reporting subsequent VMS, after adjustment for socio-demographic and reproductive factors.
Conclusions
These are the first ever findings from pooled observational data of association between consumption of soy products and VMS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013:Cd001395.
Gold EB, Colvin A, Avis N, Bromberger J, Greendale GA, Powell L, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women’s health across the nation. Am J Public Health. 2006;96:1226–35.
Rapkin AJ. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment. Am J Obstet Gynecol. 2007;196:97–106.
Pines A. Vasomotor symptoms and cardiovascular disease risk. Climacteric. 2011;14:535–6.
Biglia N, Cagnacci A, Gambacciani M, Lello S, Maffei S, Nappi RE. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017;20:306–12.
Levis S, Griebeler ML. The role of soy foods in the treatment of menopausal symptoms. J Nutr. 2010;140:2318s–2321s.
Baber R. Phytoestrogens and post reproductive health. Maturitas. 2010;66:344–9.
Sievert LL, Morrison L, Brown DE, Reza AM. Vasomotor symptoms among Japanese-American and European-American women living in Hilo, Hawaii. Menopause. 2007;14:261–9.
Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J Epidemiol. 2001;153:790–3.
Carmignani LO, Pedro AO, Costa-Paiva LH, Pinto-Neto AM. The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial. Maturitas. 2010;67:262–9.
Khaodhiar L, Ricciotti HA, Li L, Pan W, Schickel M, Zhou J, et al. Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Menopause. 2008;15:125–32.
Ye YB, Wang ZL, Zhuo SY, Lu W, Liao HF, Verbruggen M, et al. Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial. Menopause. 2012;19:791–8.
Mishra GD, Chung HF, Pandeya N, Dobson AJ, Jones L, Avis NE, et al. The InterLACE study: design, data harmonization and characteristics across 20 studies on women’s health. Maturitas. 2016;92:176–85.
Mishra GD, Anderson D, Schoenaker DA, Adami HO, Avis NE, Brown D, et al. InterLACE: A New International Collaboration for a Life Course Approach to Women’s Reproductive Health and Chronic Disease Events. Maturitas. 2013;74:235–40.
Lee C, Dobson AJ, Brown WJ, Bryson L, Byles J, Warner-Smith P, et al. Cohort Profile: the Australian Longitudinal Study on Women’s Health. Int J Epidemiol. 2005;34:987–91.
Marmot M, Brunner E. Cohort Profile: the Whitehall II study. Int J Epidemiol. 2005;34:251–6.
Mitchell ES, Woods NF. Cognitive symptoms during the menopausal transition and early postmenopause. Climacteric. 2011;14:252–61.
Anderson D, Yoshizawa T, Gollschewski S, Atogami F, Courtney M. Menopause in Australia and Japan: effects of country of residence on menopausal status and menopausal symptoms. Climacteric. 2004;7:165–74.
Nutrient Data L. USDA database for the isoflavone content of selected foods, release 2.0. Beltsville, Md: U.S. Department of Agriculture; 2008.
Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer. 2006;54:184–201.
Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100:3975–4011.
Welty FK, Lee KS, Lew NS, Nasca M, Zhou JR. The association between soy nut consumption and decreased menopausal symptoms. J Women’s Health. 2007;16:361–9.
Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM. Isoflavone treatment for acute menopausal symptoms. Menopause. 2007;14:468–73.
Nahas EA, Nahas-Neto J, Orsatti FL, Carvalho EP, Oliveira ML, Dias R. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Maturitas. 2007;58:249–58.
Burke GL, Legault C, Anthony M, Bland DR, Morgan TM, Naughton MJ, et al. Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Menopause. 2003;10:147–53.
Penotti M, Fabio E, Modena AB, Rinaldi M, Omodei U, Viganó P. Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertil Steril. 2003;79:1112–7.
Williamson-Hughes PS, Flickinger BD, Messina MJ, Empie MW. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause. 2006;13:831–9.
Sturdee DW. The menopausal hot flush—anything new? Maturitas. 2008;60:42–49.
Pachman DR, Jones JM, Loprinzi CL. Management of menopause-associated vasomotor symptoms: current treatment options, challenges and future directions. Int J Women’s Health. 2010;2:123–35.
Moreira AC, Silva AM, Santos MS, Sardão VA. Phytoestrogens as alternative hormone replacement therapy in menopause: what is real, what is unknown. J Steroid Biochem Mol Biol. 2014;143:61–71.
Rietjens I, Louisse J, Beekmann K. The potential health effects of dietary phytoestrogens. Br J Pharmacol. 2017;174:1263–80.
Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139:4252–63.
Morrow PKH, Mattair DN, Hortobagyi GN. Hot flashes: a review of pathophysiology and treatment modalities. Oncologist. 2011;16:1658–64.
Setchell KDR, Cole SJ. Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling. J Agric Food Chem. 2003;51:4146–55.
Luoto R. Hot flushes and quality of life during menopause. BMC Women’s Health. 2009;9:13.
Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. Symptoms of menopause—global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14:199–215.
Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women’s lives. Am J Med. 2005;118(Suppl 12B):14–24.
Acknowledgements
The data on which this research are based were drawn from five observational studies. The research included data from the ALSWH, the University of Newcastle, Australia, and the University of Queensland, Australia. We are grateful to the Australian Government Department of Health for funding and to the women who provided the survey data. SMWHS was supported in part by grants from the National Institute of Nursing Research. HOW and JMWHS (also called Australian and Japanese Midlife Women’s Health Study) were supported by the Queensland University of Technology Early Career Research Grant and the JSPS Grant-in-aid for Scientific Research. The Whitehall II study is supported by grants from the Medical Research Council (K013351), British Heart Foundation (BHF RG/16/11/32334) and US National Institutes on Aging (R01AG013196 and R01AG034454). All study teams would like to thank the participants for volunteering their time to be involved in the respective studies. The findings and views in this paper are not those from the original studies or their respective funding agencies.
Funding
InterLACE project is funded by the Australian National Health and Medical Research Council project grant (APP1027196). GDM is supported by the Australian National Health and Medical Research Council Principal Research Fellowship (APP1121844). YD is in receipt of a scholarship from the Commonwealth Scholarship Commission, UK. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
The authors’ responsibilities were as follows—GDM: conceived the study; YD, HFC and GDM: designed the research and had primary responsibility for the final content; JEC, DCG, AJD, ESM, NFW, EJB, TY and DA: contributed to the data; YD: performed the statistical analysis and wrote the manuscript; HFC, DCG, JEC, AJD and GDM: provided statistical input, helped with interpretation of the results and reviewed the manuscript for important intellectual content; and all authors: read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
JEC is the director of a university spin out company, Dietary Assessment Ltd. The remaining authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Sources of support: Commonwealth Scholarship, Australian National Health and Medical Research Council project grant (APP1027196 & APP1121844)
Supplementary information
Rights and permissions
About this article
Cite this article
Dunneram, Y., Chung, HF., Cade, J.E. et al. Soy intake and vasomotor menopausal symptoms among midlife women: a pooled analysis of five studies from the InterLACE consortium. Eur J Clin Nutr 73, 1501–1511 (2019). https://doi.org/10.1038/s41430-019-0398-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-019-0398-9
This article is cited by
-
Soy intake and chronic disease risk: findings from prospective cohort studies in Japan
European Journal of Clinical Nutrition (2021)